Coffee isn’t guaranteed – but now it is – with the same tech Enthereal uses applied to the world’s favorite brew
When you’re reading this about the future of coffee production (link immediately below), think about how your essential medicines, psychedelics, or MDMA were made.
Cell-based coffee future-proofs world’s favorite brew – Nature Biotechnology
Your next caffeine jolt could come from a lab. Scientists from Pluri Biotech, a regenerative medicine and cultivated meat company based in Haifa, Israel, propose to make coffee without the need to grow the entire plant. Coffee crops are expected to be hit hard by climate change. Arabica, Coffea arabica, which is the world’s most popular coffee and has been harvested for millennia, is threatened with extinction from climate change and the spread of fungal pathogens. Cell-based coffee could prove the solution to a shrinking supply of coffee and an ever-increasing number of coffee drinkers.
Nature Biotechnology volume 42, page 350 (2024)
Now, consider that sources of the feedstocks for essential medicines, psychedelics, MDMA, and even particular cannabis products — they may not be sustainable nor readily scalable. Even today.
- Your MDMA came from likely endangered trees — or from a petrochemical source (thanks to the MAPS synthesis, not very sustainability-minded, but they’re not sustainability people)
- Your coffee was likely grown where it is not sustainable, if it’s even ethically-produced
And Enthereal is the only company with the IP, the know-how, and can-do to have a viable cell-based route to MDMA, non-cactus mescaline, epinephrine, and others (including ketamine)
The people in pharma who know about this keep tight lips. But it does keep them up at night.
We at Enthereal know about it because our founder made it her life’s work about understanding and improving where important material things flow from:
– transportation and liquid fuels from 2003 to 2009 (biodiesel and biofuels)
– sustainable materials and packaging (bioplastics) from 2007 and on, and intensely over 2011 to 2014
– essential medicines from 2021, and I’ll mention CPG, ag, cannabis, and supplements, too, since they all have a lot in common.
And along the way, we distilled training and the fastest ways to learn about key ideas that have changed the game for others – and perhaps, one day, a team near you.
So when you think about where your coffee will come from when all of the supply chains are disrupted due to pandemic, geopolitics, or pollution / climate — consider that Enthereal has been working on building resilience for essential medicines through applying systems and continuous improvement across the economy (yes, we do need environmentally benign rocket launches and Elon’s not doing it!).
I’ll be forever looking to build my team.
Enthereal will continue to seek and advance with team, resources, and support.
We’ve made it a priority to reduce the complexity of essential medicines production with the IP collection growth Kiya Kersh leads with Enthereal.
We’re currently working on bio-ketamine, mescaline, the 2C intermediate, the world’s first bio-amphetamine pathway, a new flexible way to bio-cathionones, an easy way to make the methylenedioxy substituent, and a flexible way to do …
well, you’ll have to connect with us more to learn more.
Thank you for telling people about what we are doing at Enthereal!
Leave a Reply